A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

Professor Amy Berrington explains how she and a team of scientists from around the world took on the challenge of updating a classic text for cancer researchers.

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Researchers are a step closer to revolutionising how doctors use radiotherapy to treat patients with muscle-invasive bladder ...

Professor Martin Kaiser is the Chair of Haematology, group leader of the Myeloma Molecular Therapy group, and an Honorary Consultant Haematologist at The Royal Marsden NHS Foundation Trust. Group: ...

Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in the ...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, ...

An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading ...

Postdoctoral researchers – also known as postdocs – are essential to scientific research. After completing their doctoral studies, a researcher might choose to continue their training and academic ...

Help us reach the finishing line. Join us in the 'Marathon of Hope'. After another successful Terry Fox Run in London last year, we’re so excited to run together again in 2024. Help to continue ...